Correlation Between SAB Biotherapeutics and Pmv Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SAB Biotherapeutics and Pmv Pharmaceuticals, you can compare the effects of market volatilities on SAB Biotherapeutics and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Pmv Pharmaceuticals.

Diversification Opportunities for SAB Biotherapeutics and Pmv Pharmaceuticals

0.6

Correlation Coefficient

SAB Biotherapeutics  Pmv Pharmaceuticals

Poor diversification

The 3 months correlation between SAB and Pmv is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Pmv Pharmaceuticals go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Pmv Pharmaceuticals

Given the investment horizon of 90 days SAB Biotherapeutics is expected to under-perform the Pmv Pharmaceuticals. In addition to that, SAB Biotherapeutics is 1.58 times more volatile than Pmv Pharmaceuticals. It trades about -0.05 of its total potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.02 per unit of volatility. If you would invest  231.00  in Pmv Pharmaceuticals on September 3, 2024 and sell it today you would lose (62.00) from holding Pmv Pharmaceuticals or give up 26.84% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

SAB Biotherapeutics  vs.  Pmv Pharmaceuticals

SAB Biotherapeutics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, SAB Biotherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pmv Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Pmv Pharmaceuticals is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with SAB Biotherapeutics and Pmv Pharmaceuticals

The main advantage of trading using opposite SAB Biotherapeutics and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.

The idea behind SAB Biotherapeutics and Pmv Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.